WeVote
Log In

Bill

Bill

HB 37

Relating to abortion, including civil liability for distribution of abortion-inducing drugs; making conforming changes and harmonizing conforming provisions; authorizing a private civil right of action.

89th Legislature, 1st Called Session (2025) Introduced by Jared Patterson

Texas bill establishing civil liability and private lawsuits for distributing abortion-inducing drugs, expanding enforcement beyond criminal penalties.

Filed
#abortion(i0005) #computers&software(s2425) #civilremedies&liabilities(i0065) #courts--civilprocedure(i0135) #crimes--miscellaneous(i0200) #electronicinformationsystems(i0311) #mailorder(s0386) #medicine&prescriptiondrugs(s7338) #women&childprotectionact(p71x8)
0
WeVote Research Nonpartisan
Bill Summary · HB 37

Legislative bill overview

HB 37 proposes to establish civil liability for the distribution of abortion-inducing drugs in Texas and creates a private right of action allowing individuals to sue those involved in providing such drugs. The bill would expand legal mechanisms beyond criminal penalties to enable private citizens to bring lawsuits related to medication abortion distribution.

Why is this important

This legislation would create a new category of civil exposure for healthcare providers, pharmacists, and others involved in medication abortion access. It represents an expansion of enforcement mechanisms that could significantly impact the practical availability of medication abortion in Texas, regardless of federal legal status.

Potential points of contention

  • Definition and scope: The bill's precise definition of "abortion-inducing drugs" and who can be held liable (doctors, pharmacists, patients, family members, etc.) will determine its practical reach and whether it extends to medication prescribed for other medical purposes
  • Constitutional questions: Federal courts have blocked similar "private enforcement" abortion restrictions in other states, raising questions about whether this bill could survive legal challenge under First Amendment and Commerce Clause grounds
  • Interstate commerce impact: The provision could affect mail delivery of FDA-approved medications across state lines and create enforcement questions regarding out-of-state providers or telemedicine services

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.